Concepts (121)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Quinazolinones | 3 | 2012 | 7 | 1.070 |
Why?
|
| Piperidines | 3 | 2012 | 120 | 0.990 |
Why?
|
| Urinary Bladder | 4 | 2013 | 183 | 0.620 |
Why?
|
| Tissue Adhesions | 2 | 2012 | 12 | 0.470 |
Why?
|
| Urinary Bladder, Neurogenic | 2 | 2013 | 18 | 0.420 |
Why?
|
| Fetal Diseases | 2 | 2010 | 19 | 0.410 |
Why?
|
| Urethra | 2 | 2011 | 100 | 0.390 |
Why?
|
| Cecum | 1 | 2012 | 10 | 0.380 |
Why?
|
| Keratins | 1 | 2012 | 37 | 0.380 |
Why?
|
| Nocturnal Enuresis | 1 | 2011 | 1 | 0.370 |
Why?
|
| Rectum | 1 | 2011 | 17 | 0.360 |
Why?
|
| Urination | 2 | 2008 | 16 | 0.340 |
Why?
|
| Chitosan | 1 | 2010 | 3 | 0.340 |
Why?
|
| Muscle, Smooth | 3 | 2013 | 69 | 0.340 |
Why?
|
| Uterine Diseases | 1 | 2010 | 9 | 0.340 |
Why?
|
| Hydronephrosis | 1 | 2010 | 12 | 0.340 |
Why?
|
| Urethral Diseases | 1 | 2011 | 17 | 0.340 |
Why?
|
| Amnion | 1 | 2010 | 37 | 0.330 |
Why?
|
| Urethral Obstruction | 1 | 2009 | 4 | 0.310 |
Why?
|
| Urodynamics | 1 | 2008 | 36 | 0.280 |
Why?
|
| Membrane Proteins | 1 | 2008 | 251 | 0.250 |
Why?
|
| Hemofiltration | 1 | 2006 | 3 | 0.240 |
Why?
|
| Urinary Bladder, Overactive | 1 | 2006 | 16 | 0.240 |
Why?
|
| Penis | 1 | 2006 | 35 | 0.240 |
Why?
|
| Erectile Dysfunction | 1 | 2006 | 50 | 0.230 |
Why?
|
| Muscle Contraction | 1 | 2006 | 113 | 0.230 |
Why?
|
| Rats, Sprague-Dawley | 3 | 2012 | 754 | 0.230 |
Why?
|
| Postural Balance | 1 | 2016 | 180 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 196 | 0.200 |
Why?
|
| Rats | 3 | 2012 | 1606 | 0.200 |
Why?
|
| Occupational Exposure | 1 | 2016 | 231 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 240 | 0.190 |
Why?
|
| Transients and Migrants | 1 | 2016 | 298 | 0.190 |
Why?
|
| Animals | 6 | 2012 | 7569 | 0.190 |
Why?
|
| Female | 9 | 2016 | 20261 | 0.170 |
Why?
|
| Male | 10 | 2016 | 19641 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 930 | 0.160 |
Why?
|
| Humans | 11 | 2016 | 32798 | 0.130 |
Why?
|
| Child, Preschool | 4 | 2016 | 1282 | 0.130 |
Why?
|
| Spermatogenesis | 1 | 2016 | 47 | 0.120 |
Why?
|
| Cryopreservation | 1 | 2016 | 57 | 0.120 |
Why?
|
| Testis | 1 | 2016 | 65 | 0.120 |
Why?
|
| Child | 4 | 2016 | 2478 | 0.110 |
Why?
|
| Absorbable Implants | 1 | 2013 | 25 | 0.100 |
Why?
|
| Cell Transplantation | 1 | 2013 | 64 | 0.100 |
Why?
|
| Adolescent | 4 | 2016 | 3638 | 0.100 |
Why?
|
| Laxatives | 1 | 2011 | 2 | 0.090 |
Why?
|
| Dilatation, Pathologic | 1 | 2011 | 20 | 0.090 |
Why?
|
| Constipation | 1 | 2011 | 11 | 0.090 |
Why?
|
| Anal Canal | 1 | 2011 | 20 | 0.090 |
Why?
|
| Manometry | 1 | 2011 | 20 | 0.090 |
Why?
|
| Delayed Diagnosis | 1 | 2011 | 17 | 0.090 |
Why?
|
| Polyethylene Glycols | 1 | 2011 | 64 | 0.090 |
Why?
|
| Cellulose, Oxidized | 1 | 2010 | 3 | 0.090 |
Why?
|
| Collagen Type I | 1 | 2011 | 42 | 0.080 |
Why?
|
| Staining and Labeling | 1 | 2011 | 57 | 0.080 |
Why?
|
| Laparotomy | 1 | 2010 | 30 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2010 | 38 | 0.080 |
Why?
|
| Vascular Endothelial Growth Factor A | 1 | 2011 | 117 | 0.080 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2010 | 44 | 0.080 |
Why?
|
| Treatment Outcome | 2 | 2010 | 3438 | 0.080 |
Why?
|
| Cicatrix | 1 | 2011 | 39 | 0.080 |
Why?
|
| Abdomen | 1 | 2010 | 46 | 0.080 |
Why?
|
| Tissue Scaffolds | 1 | 2013 | 421 | 0.080 |
Why?
|
| Uterus | 1 | 2010 | 79 | 0.080 |
Why?
|
| Random Allocation | 1 | 2010 | 229 | 0.080 |
Why?
|
| Ischemia | 1 | 2010 | 104 | 0.080 |
Why?
|
| Valproic Acid | 1 | 2010 | 14 | 0.080 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2010 | 21 | 0.080 |
Why?
|
| Azacitidine | 1 | 2010 | 28 | 0.080 |
Why?
|
| Hydroxamic Acids | 1 | 2010 | 21 | 0.080 |
Why?
|
| Prenatal Diagnosis | 1 | 2009 | 26 | 0.080 |
Why?
|
| Stem Cell Transplantation | 1 | 2011 | 212 | 0.080 |
Why?
|
| Stents | 1 | 2011 | 174 | 0.080 |
Why?
|
| Epigenesis, Genetic | 1 | 2010 | 107 | 0.080 |
Why?
|
| Collagen | 1 | 2010 | 219 | 0.070 |
Why?
|
| Stem Cells | 1 | 2011 | 314 | 0.070 |
Why?
|
| Infant, Newborn | 1 | 2010 | 694 | 0.070 |
Why?
|
| Pilot Projects | 1 | 2010 | 565 | 0.070 |
Why?
|
| Cells, Cultured | 1 | 2010 | 820 | 0.070 |
Why?
|
| Pregnancy | 1 | 2010 | 981 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2011 | 1012 | 0.070 |
Why?
|
| Kidney | 1 | 2010 | 520 | 0.060 |
Why?
|
| Mice, Knockout | 1 | 2008 | 453 | 0.060 |
Why?
|
| Adult | 4 | 2016 | 9560 | 0.060 |
Why?
|
| Mice | 2 | 2011 | 2511 | 0.060 |
Why?
|
| Penile Erection | 1 | 2006 | 21 | 0.060 |
Why?
|
| Muscle, Smooth, Vascular | 1 | 2006 | 62 | 0.060 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2006 | 72 | 0.060 |
Why?
|
| Postoperative Complications | 1 | 2010 | 828 | 0.060 |
Why?
|
| Prognosis | 1 | 2009 | 1544 | 0.060 |
Why?
|
| Intensive Care Units | 1 | 2006 | 115 | 0.060 |
Why?
|
| Nephrostomy, Percutaneous | 1 | 2004 | 17 | 0.060 |
Why?
|
| Kidney Calculi | 1 | 2004 | 23 | 0.050 |
Why?
|
| North Carolina | 2 | 2016 | 1546 | 0.050 |
Why?
|
| Aged | 3 | 2016 | 10538 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 876 | 0.050 |
Why?
|
| Retrospective Studies | 1 | 2011 | 3701 | 0.050 |
Why?
|
| Middle Aged | 3 | 2016 | 12125 | 0.050 |
Why?
|
| Length of Stay | 1 | 2004 | 329 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2006 | 686 | 0.050 |
Why?
|
| Tissue Banks | 1 | 2016 | 14 | 0.030 |
Why?
|
| Infertility, Male | 1 | 2016 | 24 | 0.030 |
Why?
|
| Patient Care Team | 1 | 2016 | 123 | 0.030 |
Why?
|
| Spinal Dysraphism | 1 | 2013 | 3 | 0.030 |
Why?
|
| Anastomosis, Surgical | 1 | 2013 | 57 | 0.030 |
Why?
|
| Transplantation, Autologous | 1 | 2013 | 84 | 0.030 |
Why?
|
| Urothelium | 1 | 2013 | 55 | 0.030 |
Why?
|
| Urologic Surgical Procedures | 1 | 2013 | 64 | 0.020 |
Why?
|
| Infant | 1 | 2016 | 1083 | 0.020 |
Why?
|
| Vesico-Ureteral Reflux | 1 | 2011 | 20 | 0.020 |
Why?
|
| Urine | 1 | 2011 | 65 | 0.020 |
Why?
|
| Urinary Incontinence, Stress | 1 | 2011 | 66 | 0.020 |
Why?
|
| Neoplasms | 1 | 2016 | 761 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 2327 | 0.020 |
Why?
|
| Hospitals, University | 1 | 2004 | 31 | 0.010 |
Why?
|
| Young Adult | 1 | 2011 | 2730 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2004 | 682 | 0.010 |
Why?
|
| Comorbidity | 1 | 2004 | 573 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2004 | 4032 | 0.010 |
Why?
|
| Risk Factors | 1 | 2004 | 3974 | 0.010 |
Why?
|